New research indicates a significant association between gut microbiota and breast cancer. A study analyzing untreated postmenopausal patients found distinct differences in microbial diversity and composition compared to healthy individuals.
Analysis revealed notable disparities in overall microbial diversity between breast cancer groups and controls, particularly in patients with ER+HER2- disease. Beta diversity analyses also showed a significant separation, suggesting alterations in gut bacteria are linked to the presence of breast cancer.
Specific microbial genera were identified as being associated with breast cancer. Akkermansia, a genus important for gut barrier function, was found to be reduced in patients with ER+HER2- breast cancer. These compositional shifts suggest that changes in the gut microbiome may influence tumor biology and cancer development.
The findings highlight the potential for gut microbiota profiling as a future non-invasive biomarker for improved breast cancer screening or prevention strategies. Further research is needed to understand the precise mechanisms and potential for microbial community modulation.